PDF herunterladen
Semin Musculoskelet Radiol 2020; 24(03): 256-261
DOI: 10.1055/s-0040-1708087
Review Article

Biological Basis of Treatments of Acute Muscle Injuries: A Short Review

Ian Beggs
1   Analytic Imaging, Edinburgh, United Kingdom
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Muscle strains occur frequently in recreational and professional sports. This article considers various treatment options in a biological context and reviews evidence of their efficacy. Treatments reviewed include the PRICE principle (Protection, Rest, Ice, Compression, Elevation), early mobilization, physical therapy, hematoma aspiration, platelet-rich plasma injections, use of nonsteroidal anti-inflammatory drugs, corticosteroids, and local anesthetics, cellular therapies, and surgery.

Keywords

acute muscle injuries - biology - treatments - efficacy


Publikationsverlauf

Artikel online veröffentlicht:
28. September 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 

  • References

  • 1 Lee KS. Platelet-rich plasma injection. Semin Musculoskelet Radiol 2013; 17 (01) 91-98
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Sciorati C, Rigamonti E, Manfredi AA, Rovere-Querini P. Cell death, clearance and immunity in the skeletal muscle. Cell Death Differ 2016; 23 (06) 927-937
    CrossrefPubMedGoogle Scholar
  • 3 Qazi TH, Duda GN, Ort MJ, Perka C, Geissler S, Winkler T. Cell therapy to improve regeneration of skeletal muscle injuries. J Cachexia Sarcopenia Muscle 2019; 10 (03) 501-516
    CrossrefPubMedGoogle Scholar
  • 4 Järvinen TA, Järvinen TL, Kääriäinen M. , et al. Muscle injuries: optimising recovery. Best Pract Res Clin Rheumatol 2007; 21 (02) 317-331
    CrossrefPubMedGoogle Scholar
  • 5 Baoge L, Van Den Steen E, Rimbaut S. , et al. Treatment of skeletal muscle injury: a review. ISRN Orthop 2012; 2012: 689012
    CrossrefPubMedGoogle Scholar
  • 6 Hotfiel T, Seil R, Bily W. , et al. Nonoperative treatment of muscle injuries—recommendations from the GOTS expert meeting. J Exp Orthop 2018; 5 (01) 24
    CrossrefPubMedGoogle Scholar
  • 7 Bisciotti GN, Volpi P, Amato M. , et al. Italian consensus conference on guidelines for conservative treatment on lower limb muscle injuries in athlete. BMJ Open Sport Exerc Med 2018; 4 (01) e000323
    CrossrefPubMedGoogle Scholar
  • 8 Bayer ML, Magnusson SP, Kjaer M. Tendon Research Group Bispebjerg. Early versus delayed rehabilitation after acute muscle injury. N Engl J Med 2017; 377 (13) 1300-1301
    CrossrefPubMedGoogle Scholar
  • 9 Garg K, Corona BT, Walters TJ. Therapeutic strategies for preventing skeletal muscle fibrosis after injury. Front Pharmacol 2015; 6: 87
    CrossrefPubMedGoogle Scholar
  • 10 Askling CM, Tengvar M, Thorstensson A. Acute hamstring injuries in Swedish elite football: a prospective randomised controlled clinical trial comparing two rehabilitation protocols. Br J Sports Med 2013; 47 (15) 953-959
    CrossrefPubMedGoogle Scholar
  • 11 Askling CM, Tengvar M, Tarassova O, Thorstensson A. Acute hamstring injuries in Swedish elite sprinters and jumpers: a prospective randomised controlled clinical trial comparing two rehabilitation protocols. Br J Sports Med 2014; 48 (07) 532-539
    CrossrefPubMedGoogle Scholar
  • 12 Draghi F, Robotti G, Jacob D, Bianchi S. Interventional musculoskeletal ultrasonography: precautions and contraindications. J Ultrasound 2010; 13 (03) 126-133
    CrossrefPubMedGoogle Scholar
  • 13 Lee JC, Mitchell AWM, Healy JC. Imaging of muscle injury in the elite athlete. Br J Radiol 2012; 85 (1016): 1173-1185
    CrossrefPubMedGoogle Scholar
  • 14 Orlandi D, Corazza A, Arcidiacono A. , et al. Ultrasound-guided procedures to treat sport-related muscle injuries. Br J Radiol 2016; 89 (1057): 20150484
    CrossrefPubMedGoogle Scholar
  • 15 Wood JP, Beaulieu CF. Musculotendinous injuries: sonographic-guided interventions. Semin Musculoskelet Radiol 2017; 21 (04) 470-484
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Maffulli N. Autologous blood products in musculoskeletal medicine. BMJ 2013; 346: f2979
    CrossrefPubMedGoogle Scholar
  • 17 Amin I, Gellhorn AC. Platelet-rich plasma use in musculoskeletal disorders: are the factors important in standardization well understood?. Phys Med Rehabil Clin N Am 2019; 30 (02) 439-449
    CrossrefPubMedGoogle Scholar
  • 18 Chahla J, Cinque ME, Piuzzi NS. , et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017; 99 (20) 1769-1779
    CrossrefPubMedGoogle Scholar
  • 19 Mosca MJ, Rodeo SA. Platelet-rich plasma for muscle injuries: game over or time out?. Curr Rev Musculoskelet Med 2015; 8 (02) 145-153
    CrossrefPubMedGoogle Scholar
  • 20 A Hamid MS, Yusof A, Mohamed Ali MR. Platelet-rich plasma (PRP) for acute muscle injury: a systematic review. PLOS One 2014; 9 (02) e90538
    CrossrefPubMedGoogle Scholar
  • 21 Sheth U, Dwyer T, Smith I. , et al. Does platelet-rich plasma lead to earlier return to sport when compared with conservative treatment in acute muscle injuries? A systematic review and meta-analysis. Arthroscopy 2018; 34 (01) 281-288.e1
    CrossrefPubMedGoogle Scholar
  • 22 Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev 2013; (12) CD010071
    PubMedGoogle Scholar
  • 23 Pas HIMFL, Reurink G, Tol JL, Weir A, Winters M, Moen MH. Efficacy of rehabilitation (lengthening) exercises, platelet-rich plasma injections, and other conservative interventions in acute hamstring injuries: an updated systematic review and meta-analysis. Br J Sports Med 2015; 49 (18) 1197-1205
    CrossrefPubMedGoogle Scholar
  • 24 Grassi A, Napoli F, Romandini I. , et al. Is platelet-rich plasma (PRP) effective in the treatment of acute muscle injuries? A systematic review and meta-analysis. Sports Med 2018; 48 (04) 971-989
    CrossrefPubMedGoogle Scholar
  • 25 Murray IR, Murray AD, Geeslin AG. , et al. Infographic: we need minimum reporting standards for biologics. Br J Sports Med 2019; 53 (15) 974-975
    CrossrefPubMedGoogle Scholar
  • 26 Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum information for evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am 2017; 99 (10) 809-819
    CrossrefPubMedGoogle Scholar
  • 27 Mishra DK, Fridén J, Schmitz MC, Lieber RL. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. J Bone Joint Surg Am 1995; 77 (10) 1510-1519
    CrossrefPubMedGoogle Scholar
  • 28 Reynolds JF, Noakes TD, Schwellnus MP, Windt A, Bowerbank P. Non-steroidal anti-inflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy. S Afr Med J 1995; 85 (06) 517-522
    PubMedGoogle Scholar
  • 29 Jones P, Dalziel SR, Lamdin R, Miles-Chan JL, Frampton C. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev 2015; (07) CD007789
    PubMedGoogle Scholar
  • 30 Delos D, Maak TG, Rodeo SA. Muscle injuries in athletes: enhancing recovery through scientific understanding and novel therapies. Sports Health 2013; 5 (04) 346-352
    CrossrefPubMedGoogle Scholar
  • 31 Reurink G, Goudswaard GJ, Moen MH, Weir A, Verhaar JAN, Tol JL. Myotoxicity of injections for acute muscle injuries: a systematic review. Sports Med 2014; 44 (07) 943-956
    CrossrefPubMedGoogle Scholar
  • 32 Webster MT, Manor U, Lippincott-Schwartz J, Fan C-M. Intravital imaging reveals ghost fibers as architectural units guiding myogenic progenitors during regeneration. Cell Stem Cell 2016; 18 (02) 243-252
    CrossrefPubMedGoogle Scholar
  • 33 Rossi CA, Flaibani M, Blaauw B. , et al. In vivo tissue engineering of functional skeletal muscle by freshly isolated satellite cells embedded in a photopolymerizable hydrogel. FASEB J 2011; 25 (07) 2296-2304
    CrossrefPubMedGoogle Scholar
  • 34 Bar-Nur O, Gerli MFM, Di Stefano B. , et al. Direct reprogramming of mouse fibroblasts into functional skeletal muscle progenitors. Stem Cell Reports 2018; 10 (05) 1505-1521
    CrossrefPubMedGoogle Scholar
  • 35 Lorant J, Saury C, Schleder C. , et al. Skeletal muscle regenerative potential of human MuStem cells following transplantation into injured mice muscle. Mol Ther 2018; 26 (02) 618-633
    CrossrefPubMedGoogle Scholar
  • 36 Matthias N, Hunt SD, Wu J. , et al. Volumetric muscle loss injury repair using in situ fibrin gel cast seeded with muscle-derived stem cells (MDSCs). Stem Cell Res (Amst) 2018; 27: 65-73
    CrossrefPubMedGoogle Scholar
  • 37 Meng J, Chun S, Asfahani R, Lochmüller H, Muntoni F, Morgan J. Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice. Mol Ther 2014; 22 (05) 1008-1017
    CrossrefPubMedGoogle Scholar
  • 38 Kowalski K, Dos Santos M, Maire P, Ciemerych MA, Brzoska E. Induction of bone marrow-derived cells myogenic identity by their interactions with the satellite cell niche. Stem Cell Res Ther 2018; 9 (01) 258
    CrossrefPubMedGoogle Scholar
  • 39 Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011; 9 (01) 11-15
    CrossrefPubMedGoogle Scholar
  • 40 Geissler S, Textor M, Kühnisch J. , et al. Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS ONE 2012; 7 (12) e52700
    CrossrefPubMedGoogle Scholar
  • 41 Megges M, Geissler S, Duda GN, Adjaye J. Generation of an iPS cell line from bone marrow derived mesenchymal stromal cells from an elderly patient. Stem Cell Res (Amst) 2015; 15 (03) 565-568
    CrossrefPubMedGoogle Scholar
  • 42 Law PK, Goodwin TG, Fang Q. , et al. Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplant 1992; 1 (2-3): 235-244
    CrossrefPubMedGoogle Scholar
  • 43 Winkler T, Perka C, von Roth P. , et al. Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty. J Cachexia Sarcopenia Muscle 2018; 9 (05) 880-897
    CrossrefPubMedGoogle Scholar
  • 44 Cable J, Fuchs E, Weissman I. , et al. Adult stem cells and regenerative medicine-a symposium report. Ann N Y Acad Sci 2019 ; October 26 (Epub ahead of print)
    PubMedGoogle Scholar
  • 45 Järvinen TA, Järvinen TL, Kääriäinen M, Kalimo H, Järvinen M. Muscle injuries: biology and treatment. Am J Sports Med 2005; 33 (05) 745-764
    CrossrefPubMedGoogle Scholar
  • 46 Subbu R, Benjamin-Laing H, Haddad F. Timing of surgery for complete proximal hamstring avulsion injuries: successful clinical outcomes at 6 weeks, 6 months, and after 6 months of injury. Am J Sports Med 2015; 43 (02) 385-391
    CrossrefPubMedGoogle Scholar
  • 47 Kanlic EM, Pinski SE, Verwiebe EG, Saller J, Smith WR. Acute morbidity and complications of thigh compartment syndrome: a report of 26 cases. Patient Saf Surg 2010; 4 (01) 13
    CrossrefPubMedGoogle Scholar
  • 48 Ramos LA, de Carvalho RT, Abdalla RJ, Ingham SJM. Surgical treatment for muscle injuries. Curr Rev Musculoskelet Med 2015; 8 (02) 188-192
    CrossrefPubMedGoogle Scholar
  • 49 Grasman JM, Zayas MJ, Page RL, Pins GD. Biomimetic scaffolds for regeneration of volumetric muscle loss in skeletal muscle injuries. Acta Biomater 2015; 25: 2-15
    CrossrefPubMedGoogle Scholar
  • 50 Nakayama KH, Shayan M, Huang NF. Engineering biomimetic materials for skeletal muscle repair and regeneration. Adv Healthc Mater 2019; 8 (05) e1801168
    CrossrefPubMedGoogle Scholar
  • 51 Baird EO, Kang QK. Prophylaxis of heterotopic ossification - an updated review. J Orthop Surg Res 2009; 4: 12
    CrossrefPubMedGoogle Scholar
  • 52 Ploumis A, Donovan JM, Olurinde MO. , et al. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury. J Spinal Cord Med 2015; 38 (02) 193-198
    CrossrefPubMedGoogle Scholar
  • 53 Parikh J, Hyare H, Saifuddin A. The imaging features of post-traumatic myositis ossificans, with emphasis on MRI. Clin Radiol 2002; 57 (12) 1058-1066
    CrossrefPubMedGoogle Scholar
  • 54 Orava S, Sinikumpu JJ, Sarimo J, Lempainen L, Mann G, Hetsroni I. Surgical excision of symptomatic mature posttraumatic myositis ossificans: characteristics and outcomes in 32 athletes. Knee Surg Sports Traumatol Arthrosc 2017; 25 (12) 3961-3968
    CrossrefPubMedGoogle Scholar
  • 55 Reichl FX, Holdt LM, Teupser D. , et al. Comprehensive analytics of Actovegin® and its effect on muscle cells. Int J Sports Med 2017; 38 (11) 809-818
    Artikel in Thieme ConnectPubMedGoogle Scholar